1734
285
185
98
84
79
69
65
64
58
57
53
44
43
40
37
37
37
34
31
31
30
30
29
26
25
24
22
21
19
19
17
17
17
16
16
15
15
14
14
13
12
12
12
12
12
12
11
11
11
10
10
9
9
8
8
8
7
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
12649
1264
3699
369
3469
346
Journal of The National Comprehensive Cancer Network
HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials
PDF的下载单位、IP信息已删除
(2025-6-4)